Literature DB >> 3384470

The reproducibility of average ambulatory, home, and clinic pressures.

G D James1, T G Pickering, L S Yee, G A Harshfield, S Riva, J H Laragh.   

Abstract

The reproducibility of ambulatory, home, and clinic blood pressures was compared in 13 untreated mildly hypertensive and 14 normotensive subjects. Each subject had two sets of daily ambulatory recordings, home self-measured readings (over 6 days), and clinic measurements taken 2 weeks apart. Comparisons over the 2 weeks within and among the methods of measurements were made using a repeated-measures analysis of variance. The results showed that there was no consistent average change in the ambulatory or home pressures and no change in clinic diastolic pressures, but the clinic systolic pressure of the hypertensive subjects dropped 6 mm Hg (p less than 0.05), while that of the normotensive subjects showed no significant change. Test-retest correlations of each of the three methods were similar in magnitude, indicating a similar level of reliability. Test-retest correlations of the ambulatory standard deviations, however, were low, indicating a low reliability of this measure of daily pressure variability. These results suggest that the reproducibility of ambulatory pressures may be as good or better than that of home or clinic measurements. They also suggest that the average ambulatory pressure may be preferable as the measurement in clinical trials, since it may be less influenced by measurement anxiety, particularly in hypertensive subjects.

Entities:  

Mesh:

Year:  1988        PMID: 3384470     DOI: 10.1161/01.hyp.11.6.545

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

1.  Measurement and interpretation of blood pressure.

Authors:  C D Goonasekera; M J Dillon
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Reference data for ambulatory blood pressure monitoring: what results are equivalent to the established limits of office blood pressure?

Authors:  P Baumgart; P Walger; U Jürgens; K H Rahn
Journal:  Klin Wochenschr       Date:  1990-07-17

3.  Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

Authors:  Focke Ziemssen; Qi Zhu; Swaantje Peters; Salvatore Grisanti; Mohammed El Wardani; Peter Szurman; Karl U Bartz-Schmidt; Tjalf Ziemssen
Journal:  Int Ophthalmol       Date:  2008-04-17       Impact factor: 2.031

4.  The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.

Authors:  Michael B Saddekni; Kenneth G Saag; Tanja Dudenbostel; Suzanne Oparil; David A Calhoun; Sebastian E Sattui; Daniel I Feig; Paul Muntner; David T Redden; Phillip J Foster; Elizabeth J Rahn; Stephanie R Biggers; Peng Li; Angelo L Gaffo
Journal:  Contemp Clin Trials       Date:  2016-08-30       Impact factor: 2.226

5.  Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly.

Authors:  P Campbell; N Ghuman; D Wakefield; L Wolfson; W B White
Journal:  J Hum Hypertens       Date:  2010-03-04       Impact factor: 3.012

6.  Higher ambulatory blood pressure is associated with aortic valve calcification in the elderly: a population-based study.

Authors:  Shinichi Iwata; Cesare Russo; Zhezhen Jin; Joseph E Schwartz; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Ralph L Sacco; Marco R Di Tullio
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

7.  Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study.

Authors:  Hasan M Shihab; Lucy A Meoni; Audrey Y Chu; Nae-Yuh Wang; Daniel E Ford; Kung-Yee Liang; Joseph J Gallo; Michael J Klag
Journal:  Circulation       Date:  2012-11-14       Impact factor: 29.690

8.  Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.

Authors:  P Omvik; P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

9.  Predictors of the pressor response to the clinic visit in essential hypertensives with and without diabetes mellitus.

Authors:  C L Laffer; F Elijovich
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435

10.  Reproducibility of wrist home blood pressure measurement with position sensor and automatic data storage.

Authors:  Sakir Uen; Rolf Fimmers; Miriam Brieger; Georg Nickenig; Thomas Mengden
Journal:  BMC Cardiovasc Disord       Date:  2009-05-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.